Study Group: CEOs at Biotechnology Companies (?)
Council Members in this Study Group: 46
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Request a survey with this Study Group
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Cheaper AIDS Drugs and Future Development | 08-16-2007
Analysis of:
Clinton Says 66 Developing Nations To Get Cheaper AIDS Drugs | www.medicalnewstoday.com
Author: GLG Expert Contributor
- Price Gaps and Harmonization - Capitalism can exist in these price reductions
Shouldn't be a big issue to achieve reimbursement | 08-16-2007
Analysis of:
FDA approved Pfizer’s CCR5 antagonist maraviroc for HIV | www.pipelinereview.com
Author: GLG Expert Contributor
- FDA hasn't mandated the Trophile test - CCR5 class is important as a nucleoside sparing component - Patients get full reimbursement usually, so expense shouldnt' interupt treament
Avexa and ATC - Will it make a difference? | 08-16-2007
Analysis of:
Avexa positioned to launch Phase III clinical trial of ATC | www.pipelinereview.com
Author: GLG Expert Contributor
- Seems to have a good resistance profile - Ease of use - First entry into marketplace for Avexa
Seeing is Believing | 04-11-2007
Analysis of:
Ugandan, Indian Pharmaceutical Manufacturers Partner To Produce Low-Cost Antiretrovirals | www.medicalnewstoday.com
Author: GLG Expert Contributor
Manufacturing in Africa for Africans has been brought up before. The key to the success of any program like this is Access to the medicines. This will include: appropriate distribution, clinical training, accounting, weeding out corruption, patient compliance and total government...
Most Common Company Types:
- Biotechnology Manufacturer
- Academic Institution*
- Individual/Small Consultancy
Most Common Job Types:
- Chief Executive Officer
- Professor
- President
GLG's 750+ Clients Include:
40 of the leading 50
global mutual funds
global mutual funds
15 of the leading 20
global banks
global banks
8 of the leading 10
private equity firms
private equity firms
90%+ client subscription renewal rate